These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9418826)
1. Potent topical steroid in a Chinese herbal cream. Wood B; Wishart J N Z Med J; 1997 Nov; 110(1055):420-1. PubMed ID: 9418826 [TBL] [Abstract][Full Text] [Related]
2. Skin Cap and corticosteroids. Boyce D Dermatol Online J; 1997 Dec; 3(2):11e-11f. PubMed ID: 10328674 [No Abstract] [Full Text] [Related]
3. Immediacy is both a liability and an asset of the Internet. Huntley A Dermatol Online J; 1997 Dec; 3(2):11b. PubMed ID: 10217739 [No Abstract] [Full Text] [Related]
4. Skin Cap: what have we learned, and when did we learn it? Smith K Dermatol Online J; 1997 Dec; 3(2):11c. PubMed ID: 10217740 [No Abstract] [Full Text] [Related]
5. Pharmaceutical availability of clobetasol-17-propionate from cream and ointment. Dyderski S; Grześkowiak E; Szałek E; Mrzygłód A Acta Pol Pharm; 2001; 58(6):435-8. PubMed ID: 12197615 [TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome caused by topical steroid therapy for psoriasis. Abma EM; Blanken R; De Heide LJ Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372 [TBL] [Abstract][Full Text] [Related]
7. Liquid chromatographic determination of clobetasone-17-butyrate in ointments. Patel AG; Patel RB; Patel MR J Assoc Off Anal Chem; 1990; 73(6):893-5. PubMed ID: 2289922 [TBL] [Abstract][Full Text] [Related]
8. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961 [TBL] [Abstract][Full Text] [Related]
9. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison. Lee CS; Koo J J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113 [TBL] [Abstract][Full Text] [Related]
12. Class I topical corticosteroid use by psoriasis patients in an academic practice. Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038 [TBL] [Abstract][Full Text] [Related]
13. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182 [TBL] [Abstract][Full Text] [Related]
15. Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. Carbone M; Arduino PG; Carrozzo M; Caiazzo G; Broccoletti R; Conrotto D; Bezzo C; Gandolfo S J Oral Pathol Med; 2009 Feb; 38(2):227-33. PubMed ID: 19141065 [TBL] [Abstract][Full Text] [Related]
16. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone. Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704 [TBL] [Abstract][Full Text] [Related]
17. Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid. Saeki H; Watanabe A; Tada Y; Kakinuma T; Komine M; Ihn H; Asahina A; Etoh T; Kitanaka S; Sato U; Kano H; Igarashi T; Tamaki K J Dermatol; 2008 Sep; 35(9):601-3. PubMed ID: 18837708 [No Abstract] [Full Text] [Related]
18. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. Sánchez Regaña M; Márquez Balbás G; Umbert Millet P J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337 [TBL] [Abstract][Full Text] [Related]
19. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896 [TBL] [Abstract][Full Text] [Related]
20. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis. Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]